Skip to content

A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)

A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206) - Colorectal stent (JIVROSG-0206)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-C000000044
Enrollment
33
Registered
2005-08-06
Start date
2003-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inoperable malignant colorectal strictures.

Interventions

A bare stent is placed in the stenotic portion of sigmoid colon or rectum caused by malignant tumor via the trans-anal route.

Sponsors

Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Symptomatic acute colonic obstruction due to unresectable malignant tumor of sigmoid colon or rectum. 2) Stenosis or obstruction of sigmoid colon or rectum confirmed by colography. The lesion confined within the lower margin more than 5cm distant from the anal ring, and the higher margin up to the level of the iliac crest. 3) No clinically definitive obstruction in upper gastrointestional tract other than sigmoid colon or rectal lesion. 4) Adequate cardiac, hepatic, renal, respiratory, and bone marrow functions. 5) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3. 6) Expected survival more than 4 weeks. 7) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) The operation for colostomy scheduled. 2) Stenting as the preoperative preparation for the resection. 3) Serious bleeding from the lesion. 4) Pregnancy.

Design outcomes

Primary

MeasureTime frame
Improvement of subjective symptoms at 1 day, 1,2 and 4 weeks after stenting.

Secondary

MeasureTime frame
Adverse events, improvement of abdominal radiography findings at 1 day, 1,2 and 4 weeks after stenting.

Countries

Japan

Contacts

Public ContactYasuaki Arai

JIVROSG, Coordinating Office Division of Diagnostic Radiology, National Cancer Center Hospital

jivrosgoffice@ml.res.ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026